Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Apr-24 7:30 PM View:  | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,067 | $2.63 | $2,811.54 | (4%) 27.66K to 26.59K | |
| 08-Apr-24 7:30 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,012 | $2.64 | $2,667.43 | (12%) 8.68K to 7.67K | |
| 08-Apr-24 7:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,069 | $2.63 | $2,816.81 | (18%) 5.83K to 4.76K | |
| 08-Apr-24 7:31 PM View: | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,008 | $2.64 | $2,656.18 | (25%) 4.0K to 2.99K | |
| 08-Apr-24 7:32 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 5,268 | $2.62 | $13,823.00 | (< 1%) 8.6M to 8.59M | |
| 08-Apr-24 7:32 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 165 | $2.62 | $432.48 | (3%) 5.57K to 5.41K | |
| 08-Apr-24 7:30 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 9% 25.41K to 27.66K | |
| 08-Apr-24 7:30 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 35% 6.43K to 8.68K | |
| 08-Apr-24 7:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 63% 3.58K to 5.83K | |
| 08-Apr-24 7:31 PM View: | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 08-Apr-24 7:32 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 14,000 | -- | -- | < 1% 8.58M to 8.6M | |
| 08-Apr-24 7:32 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 2,250 | -- | -- | 68% 3.32K to 5.57K | |
| 08-Apr-24 7:30 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 9% 5.91K to 6.43K | |
| 08-Apr-24 7:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 17% 3.06K to 3.58K | |
| 08-Apr-24 7:32 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 2,610 | -- | -- | < 1% 8.58M to 8.58M | |
| 08-Apr-24 7:32 PM View: | O'Neill Vincent See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 19% 2.8K to 3.32K | |
| 08-Apr-24 7:30 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-24 | Option Exercise | 521 | -- | -- | 2% 24.89K to 25.41K | |
| 18-Dec-23 4:47 PM View: | O'Neill Vincent Chief Medical Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 23% 2.28K to 2.8K | |
| 18-Dec-23 4:57 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 5% 10.54K to 11.06K | |
| 18-Dec-23 4:54 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 10% 5.39K to 5.91K | |
| 18-Dec-23 4:52 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 521 | -- | -- | 20% 2.54K to 3.06K | |
| 18-Dec-23 4:55 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 14-Dec-23 | Option Exercise | 2,609 | -- | -- | < 1% 8.58M to 8.58M | |
| 18-Sep-23 4:49 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 5% 10.02K to 10.54K | |
| 18-Sep-23 4:48 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 11% 4.87K to 5.39K | |
| 18-Sep-23 4:49 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 26% 2.02K to 2.54K | |
| 18-Sep-23 4:47 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 2,610 | -- | -- | 9% 29.0K to 31.61K | |
| 18-Sep-23 4:47 PM View: | O'Neill Vincent Chief Medical Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Sep-23 | Option Exercise | 521 | -- | -- | 30% 1.76K to 2.28K | |
| 24-May-23 4:37 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 22-May-23 | Private Sale (Planned) | 6,500 | $25.79 | $167,641.00 | (14%) 45.79K to 39.29K | |
| 16-May-23 8:29 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-May-23 | Planned Option Sale | 1,785 | $27.32 | $48,764.80 | (29%) 6.13K to 4.35K | |
| 16-May-23 8:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-May-23 | Planned Option Sale | 5,000 | $27.17 | $135,864.00 | (77%) 6.5K to 1.5K | |
| 16-May-23 8:29 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-May-23 | Option Exercise | 5,000 | -- | -- | 441% 1.14K to 6.13K | |
| 16-May-23 8:32 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-May-23 | Option Exercise | 5,000 | -- | -- | 333% 1.5K to 6.5K | |
| 16-May-23 8:33 PM View: | Mehta Vimal CEO and President | Bioxcel Therapeutics, Inc. (BTAI) | 14-May-23 | Option Exercise | 15,000 | -- | -- | 84% 17.89K to 32.89K | |
| 10-Apr-23 6:20 PM View: | Nandabalan Krishnan Director 10% Owner | Bioxcel Therapeutics, Inc. (BTAI) | 06-Apr-23 | Option Exercise | 60,000 | $0.41 | $24,600.00 | < 1% 8.55M to 8.61M | |
| 10-Apr-23 6:20 PM View: | Nandabalan Krishnan Director 10% Owner | Bioxcel Therapeutics, Inc. (BTAI) | 06-Apr-23 | Planned Option Sale | 60,000 | $17.32 | $1,039,200.00 | (< 1%) 8.61M to 8.55M | |
| 22-Mar-23 7:30 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 21-Mar-23 | Planned Option Sale | 25,500 | $19.71 | $502,694.00 | (< 1%) 8.59M to 8.57M | |
| 22-Mar-23 7:30 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 21-Mar-23 | Option Exercise | 30,000 | $0.41 | $12,300.00 | < 1% 8.56M to 8.59M | |
| 22-Mar-23 7:30 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 21-Mar-23 | Sale (Planned) | 4,500 | $19.71 | $88,710.80 | (< 1%) 8.57M to 8.56M | |
| 22-Mar-23 7:30 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 20-Mar-23 | Planned Option Sale | 34,500 | $18.32 | $631,908.00 | (< 1%) 8.6M to 8.56M | |
| 22-Mar-23 7:30 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 20-Mar-23 | Option Exercise | 30,000 | $0.41 | $12,300.00 | < 1% 8.57M to 8.6M | |
| 16-Mar-23 10:00 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-23 | Planned Option Sale | 950 | $19.62 | $18,643.80 | (46%) 2.08K to 1.14K | |
| 16-Mar-23 10:00 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-23 | Planned Option Sale | 2,084 | $19.50 | $40,638.00 | (58%) 3.58K to 1.5K | |
| 16-Mar-23 10:00 PM View: | O'Neill Vincent Chief Medical Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-23 | Planned Option Sale | 845 | $19.69 | $16,642.30 | (41%) 2.08K to 1.24K | |
| 16-Mar-23 10:00 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-23 | Planned Option Sale | 985 | $19.69 | $19,395.70 | (9%) 10.48K to 9.5K | |
| 16-Mar-23 10:00 PM View: | Mehta Vimal CEO and President Director | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-23 | Option Exercise | 10,437 | -- | -- | < 1% 8.56M to 8.57M | |
| 16-Mar-23 10:00 PM View: | Rodriguez Javier See Remarks | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-23 | Option Exercise | 2,084 | -- | -- | 100% 0 to 2.08K | |
| 16-Mar-23 10:00 PM View: | Steinhart Richard I Chief Financial Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-23 | Option Exercise | 2,084 | -- | -- | 139% 1.5K to 3.58K | |
| 16-Mar-23 10:00 PM View: | O'Neill Vincent Chief Medical Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-23 | Option Exercise | 2,084 | -- | -- | 100% 0 to 2.08K | |
| 16-Mar-23 10:00 PM View: | Yocca Frank Chief Scientific Officer | Bioxcel Therapeutics, Inc. (BTAI) | 14-Mar-23 | Option Exercise | 2,084 | -- | -- | 25% 8.4K to 10.48K | |
| 24-Jan-23 8:04 PM View: | O'Neill Vincent Chief Medical Officer | Bioxcel Therapeutics, Inc. (BTAI) | 20-Jan-23 | Planned Option Sale | 29,713 | $30.00 | $891,390.00 | (100%) 29.71K to 0 |
